Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastazia Kei

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Archives of Medical Science : AMS|August 7, 2014
Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemiaAnastazia Kei, Moses Elisaf
Expert Opinion on Drug Safety|May 9, 2012
Nicotinic acid: clinical considerationsAnastazia Kei, Moses S Elisaf
World Journal of Diabetes|January 1, 2014
Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemiaAnastazia Kei, Evangelos Liberopoulos, Moses Elisaf
Therapeutic Advances in Chronic Disease|September 4, 2015
Statin use in prediabetic patients: rationale and results to dateAnastazia Kei, Evangelos C Rizos, Moses Elisaf
Archives of Toxicology|May 12, 2016
The current role of thiazolidinediones in diabetes managementChristos V Rizos, Anastazia Kei, Moses S Elisaf
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 21, 2012
Autoimmune manifestations in patients with visceral leishmaniasisEvangelos Liberopoulos, Anastazia Kei, Fotini Apostolou, et al.
Annals of Gastroenterology|April 10, 2014
Electrolyte and acid-base disorders in inflammatory bowel diseaseFotis Barkas, Evangelos Liberopoulos, Anastazia Kei, et al.
Current Vascular Pharmacology|February 15, 2011
What restricts the clinical use of nicotinic acid?Anastazia Kei, Evangelos N Liberopoulos, Moses S Elisaf
Diseases (Basel, Switzerland)|September 30, 2017
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?Theodosios D Filippatos, Anastazia Kei, Moses S Elisaf
Hospital Practice (1995)|June 1, 2018
Diagnostic lipid changes in patients with visceral leishmaniasisVasilis Tsimihodimos, Anastazia Kei, Fotini Apostolou, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Archives of Medical Science : AMS|August 7, 2014
Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemiaAnastazia Kei, Moses Elisaf
Expert Opinion on Drug Safety|May 9, 2012
Nicotinic acid: clinical considerationsAnastazia Kei, Moses S Elisaf
World Journal of Diabetes|January 1, 2014
Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemiaAnastazia Kei, Evangelos Liberopoulos, Moses Elisaf
Therapeutic Advances in Chronic Disease|September 4, 2015
Statin use in prediabetic patients: rationale and results to dateAnastazia Kei, Evangelos C Rizos, Moses Elisaf
Archives of Toxicology|May 12, 2016
The current role of thiazolidinediones in diabetes managementChristos V Rizos, Anastazia Kei, Moses S Elisaf
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 21, 2012
Autoimmune manifestations in patients with visceral leishmaniasisEvangelos Liberopoulos, Anastazia Kei, Fotini Apostolou, et al.
Annals of Gastroenterology|April 10, 2014
Electrolyte and acid-base disorders in inflammatory bowel diseaseFotis Barkas, Evangelos Liberopoulos, Anastazia Kei, et al.
Current Vascular Pharmacology|February 15, 2011
What restricts the clinical use of nicotinic acid?Anastazia Kei, Evangelos N Liberopoulos, Moses S Elisaf
Diseases (Basel, Switzerland)|September 30, 2017
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?Theodosios D Filippatos, Anastazia Kei, Moses S Elisaf
Hospital Practice (1995)|June 1, 2018
Diagnostic lipid changes in patients with visceral leishmaniasisVasilis Tsimihodimos, Anastazia Kei, Fotini Apostolou, et al.
Pageof 3